首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1490050

关节止痛注射市场：按註射类型、按关节类型、按分销管道、按地区

Joint Pain Injections Market, By Injection Type, By Joint Type, By Distribution Channel, By Geography

出版日期: 2024年05月07日 | 出版商:

Coherent Market Insights | 英文 179 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球关节疼痛注射剂市场规模为52.9亿美元，预计2031年将达到94.6亿美元，2024年至2031年复合年增长率为8.7%。

报告范围		报告详情
基准年	2023年	2024年市场规模	52.9亿美元
实际资料	2019年至2023年	预测期	从2024年到2031年
预测 2024-2031 年复合年增长率：	8.70%	2031年价值预测	94.6亿美元

图：2024 年关节止痛注射剂市场占有率（%），依地区划分

过去几年，全球关节疼痛注射剂市场经历了稳定成长。关节疼痛可能由多种原因引起，包括关节炎、受伤以及与老龄化相关的磨损，这些磨损会导致发炎以及软骨和骨骼的损伤。关节注射可以透过直接向关节注射药物来帮助减轻疼痛并恢復活动能力。常见的关节注射有皮质类固醇注射、玻尿酸注射、富血小板血浆注射等。容易患有关节疾病的老年人口不断增加，肥胖症盛行率不断上升，推动了全球对关节疼痛注射剂的需求。此外，创新治疗方法和优惠报销政策的出现正在为该市场的参与者创造新的机会。

市场动态：

全球关节疼痛注射市场是由老年人口增加、肥胖率上升和关节炎盛行率上升所推动的。据估计，目前世界上超过 10% 的人口患有某种形式的关节炎，这种情况在女性和老年人中更为常见。此外，肥胖是膝骨关节炎的主要危险因素，肥胖率的大幅上升将进一步增加关节疼痛注射的需求。然而，高昂的治疗成本，尤其是创新生物製药的治疗成本，可能会阻碍市场成长。从积极的一面来看，先进生物製药的引入提供了新的机会。市场开拓也在增加研发投资，以开发持久、具成本效益的治疗方法，以满足未满足的需求并扩大客户群。

本研究的主要特点

该报告对全球关节疼痛注射剂市场进行了详细分析，并以2023年为基准年估计了预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
它根据公司亮点、产品系列、主要亮点、业绩和策略等参数，介绍了全球关节疼痛注射市场的主要企业。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球关节疼痛注射市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球关节疼痛注射市场时所使用的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 5.29 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.70%	2031 Value Projection:	US$ 9.46 Bn

The global joint pain injections market has been witnessing steady growth in the past few years. Joint pain arises due to various conditions like arthritis, injuries, and age-related wear and tear that lead to inflammation and damage of cartilage and bones. Joint injections help in reducing pain and restoring mobility by delivering medications directly into the joint. Some common joint injections include corticosteroid injections, hyaluronic acid injections, and platelet-rich plasma injections. The rising geriatric population prone to joint disorders as well as the growing prevalence of obesity are fueling the demand for joint pain injections globally. Additionally, the advent of innovative therapies and favorable reimbursement policies are creating new opportunities for players in this market.

Market Dynamics:

The global joint pain injections market is driven by the growing geriatric population, increasing obesity rates, and rising prevalence of arthritis. According to estimates, over 10% of the world's population suffers from some form of arthritis currently and the condition is more common in women and elderly. Moreover, obesity is a major risk factor for knee osteoarthritis and as obesity rates surge significantly, it will further propel the need for joint pain injections. However, the market growth can be hindered by the high cost of therapies especially innovative biologic products. On the positive side, infusion of advanced biologic therapies offers new opportunities. Market players are also investing more in R&D to develop long-lasting and cost-effective therapies which can address the unmet needs and expand the customer pool.

Key Features of the Study:

This report provides an in-depth analysis of the global joint pain injections market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global joint pain injections market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this Pfizer, Inc., Ferring Pharmaceuticals Inc., PACIRA BIOSCIENCES, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Sanofi, Anika Therapeutics, Inc., Bioventus, Dr. Reddy's Laboratories Ltd., Zimmer Biomet, Ferring B.V., and SEIKAGAKU CORPORATION
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global joint pain injections market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global joint pain injections market

Detailed Segmentation-

By Injection Type:
- Corticosteroid Injection
- Hyaluronic Acid Injection
- Platelet Rich Plasma Injection
- Others
By Joint Type:
- Knee and Ankle
- Hip Joint
- Hand and Wrist
- Other
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer, Inc.
- Ferring Pharmaceuticals Inc.
- PACIRA BIOSCIENCES
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Sanofi
- Anika Therapeutics, Inc.
- Bioventus
- Reddy's Laboratories Ltd.
- Zimmer Biomet
- Ferring B.V.
- SEIKAGAKU CORPORATION

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Injections Type
- Market Snapshot, By Joint Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Joint Pain Injections Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Joint Pain Injections Market, By Injections Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Corticosteroid Injections
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hyaluronic Acid Injections
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Platelet Rich Plasma Injections
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Joint Pain Injections Market, By Joint Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Knee and Ankle
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hip Joint
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hand and Wrist
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cell Immortalization Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Joint Pain Injections Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Joint Pain Injections Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Injections Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Joint Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Pfizer, Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ferring Pharmaceuticals Inc.
- PACIRA BIOSCIENCES
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Sanofi
- Anika Therapeutics, Inc.
- Bioventus
- Dr. Reddy's Laboratories Ltd.
- Zimmer Biomet
- Ferring B.V.
- SEIKAGAKU CORPORATION

10. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

关节止痛注射市场：按註射类型、按关节类型、按分销管道、按地区